Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

patient expectations

- PMLiVE

EU may seek legal action against AstraZeneca following vaccine supply cuts

EU supply issues for the AZ vaccine started in January 2021

- PMLiVE

J&J halts manufacturing of COVID-19 at US plant after FDA warning

Inspection report found facility was “not maintained in a clean and sanitary condition”

Leaders in Pharma: Samir Vattompadam

In the inaugural episode of Impetus Digital's Leaders in Pharma podcast, I sit down with Samir Vattompadam. Samir is currently Vice President, Program Executive for EQRx.

Impetus Digital

Building Better Access to Pediatric Care Through Telehealth

Jeannie Chen, Head of Clinical Operations and People at Hazel Health, shares her insights on telemedicine and virtual care as means to improve healthcare access and equity among school-aged children....

Impetus Digital

- PMLiVE

Healthware Group acquires London-headquartered consultancy SWM

Acquisition follows years of collaboration between the two companies

- PMLiVE

Lucid Group promotes Clare Reynolds to Director of Business Development and Commercial Integration

As Lucid continues to evolve, its people have remained at the heart of its success. Clare Reynolds has played a key part in Lucid’s journey for nearly 12 years, during...

Lucid Group Communications Limited

- PMLiVE

Are you ready for the digital health revolution?

In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age.

Avalere Health

- PMLiVE

Robert Wainwright and Bam Zahraie become co-managing directors of Havas NOW

Havas NOW is the innovation hub of Havas Health & You

- PMLiVE

Adding insult to injury

Hey Europe, it may be time to consider that ‘less is more’

- PMLiVE

Valneva to compare its COVID-19 vaccine candidate to AstraZeneca’s jab

Phase 3 trial will test Valneva’s vaccine candidate against Vaxzevria in approximately 4,000 participants

- PMLiVE

Oxford University, Prenetics to advance COVID-19 rapid testing for other infectious diseases

Rapid testing technology at the core of the collaboration is used in Oxford University's COVID-19 test

Biogen Idec building

Biogen reveals new data for MS therapies Tysabri and Vumerity

New data comes ahead of FDA decision on company's controversial Alzheimer’s drug aducanumab

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links